Axonics Inc (AXNX)
67.02
-0.03
(-0.04%)
USD |
NASDAQ |
Apr 19, 11:04
Axonics Cash from Financing (TTM): -3.38M for Dec. 31, 2023
Cash from Financing (TTM) Chart
Historical Cash from Financing (TTM) Data
Date | Value |
---|---|
December 31, 2023 | -3.38M |
September 30, 2023 | -3.797M |
June 30, 2023 | 127.21M |
March 31, 2023 | 134.45M |
December 31, 2022 | 133.97M |
September 30, 2022 | 134.01M |
June 30, 2022 | 3.649M |
March 31, 2022 | 115.74M |
December 31, 2021 | 170.51M |
September 30, 2021 | 171.37M |
June 30, 2021 | 171.14M |
Date | Value |
---|---|
March 31, 2021 | 200.06M |
December 31, 2020 | 144.19M |
September 30, 2020 | 253.63M |
June 30, 2020 | 252.44M |
March 31, 2020 | 111.26M |
December 31, 2019 | 110.96M |
September 30, 2019 | 136.04M |
June 30, 2019 | 135.94M |
March 31, 2019 | 135.63M |
December 31, 2018 | 165.34M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (TTM) Range, Past 5 Years
-3.797M
Minimum
Sep 2023
253.63M
Maximum
Sep 2020
131.55M
Average
134.45M
Median
Mar 2023
Cash from Financing (TTM) Benchmarks
Boston Scientific Corp | 5.00M |
Inspire Medical Systems Inc | 13.95M |
Stereotaxis Inc | 0.081M |
Electromed Inc | -0.128M |
Myomo Inc | 9.714M |